Jove
Visualize
Contact Us

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining Discordance Between Signs and Symptoms in Dry Eye Disease: Insights From the DRy Eye Assessment and Management (DREAM) Study.

American journal of ophthalmology·2026
Same author

Association between lid margin collarettes and dry eye disease severity in the Dry Eye Assessment and Management (DREAM) study.

Eye (London, England)·2025
Same author

Association of Cataract History with Dry Eye Disease Signs and Symptoms in the DREAM Study.

Clinical ophthalmology (Auckland, N.Z.)·2025
Same author

Birth of a Change Agent: The Founding of "Women in Ophthalmology".

American journal of ophthalmology·2025
Same author

Association of Conjunctival Cell HLA-DR Expression with the Severity of Signs and Symptoms of Dry Eye Disease at Baseline in the NORTHERN LIGHTS Phase 2 Trial.

Current eye research·2025
Same author

Prevalence and risk factors for the development of chronic postoperative pain after cataract surgery in the Age-related Eye Disease Study (AREDS).

The journal of pain·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 1, 2026

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

Published on: April 25, 2025

Nutritional supplements for dry eye syndrome.

Allison L Rand1, Penny A Asbell

  • 1Mount Sinai School of Medicine, New York, NY 10029, USA.

Current Opinion in Ophthalmology
|May 21, 2011
PubMed
Summary

Essential fatty acids, including omega-3 and omega-6, show promise in treating dry eye disease symptoms. Further research is needed to optimize their use as a nutritional supplement for ocular health.

Area of Science:

  • Ophthalmology
  • Nutrition Science

Background:

  • Essential fatty acids (EFAs) are recognized for their roles in systemic and ocular health.
  • Dry eye disease (DED) is a prevalent condition affecting ocular surface health and patient comfort.

Purpose of the Study:

  • To review the recent use of essential fatty acids as an adjunctive treatment for dry eye disease.
  • To evaluate the efficacy and potential mechanisms of omega-3 and omega-6 fatty acids in managing DED symptoms.

Main Methods:

  • Review of recent studies investigating systemic and topical essential fatty acid supplementation in DED patients.
  • Analysis of reported clinical outcomes and postulated anti-inflammatory effects.

Main Results:

  • Systemic and topical omega-3 and omega-6 fatty acids demonstrate efficacy in alleviating dry eye disease symptoms.

More Related Videos

Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation
06:29

Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation

Published on: May 2, 2020

Related Experiment Videos

Last Updated: Jun 1, 2026

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome
03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

Published on: April 25, 2025

Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation
06:29

Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation

Published on: May 2, 2020

  • The therapeutic effects are attributed to the known anti-inflammatory properties of these essential fatty acids.
  • Current evidence suggests a promising adjunctive role, but further investigation is required.
  • Conclusions:

    • Essential fatty acids represent a novel nutritional supplement approach for managing dry eye syndrome.
    • Standardization of indications, composition, and dosage is necessary for optimal clinical application.